FRACTAL STRUCTURE IN THE VOLUMETRIC CONTRAST ENHANCEMENT OF MALIGNANT GLIOMAS AS A MARKER OF OXIDATIVE METABOLIC PATHWAY GENE EXPRESSION
Conferences
Miller, K; Berendsen, S; Seute, T; Yeom, K; Gephardt, M; Grant, G; Robe, P
Published in: NEURO-ONCOLOGY
November 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 2016
Volume
18
Start / End Page
173 / 173
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Miller, K., Berendsen, S., Seute, T., Yeom, K., Gephardt, M., Grant, G., & Robe, P. (2016). FRACTAL STRUCTURE IN THE VOLUMETRIC CONTRAST ENHANCEMENT OF MALIGNANT GLIOMAS AS A MARKER OF OXIDATIVE METABOLIC PATHWAY GENE EXPRESSION. In NEURO-ONCOLOGY (Vol. 18, pp. 173–173).
Miller, Kai, Sharon Berendsen, Tatjana Seute, Kristen Yeom, Melanie Gephardt, Gerald Grant, and Pierre Robe. “FRACTAL STRUCTURE IN THE VOLUMETRIC CONTRAST ENHANCEMENT OF MALIGNANT GLIOMAS AS A MARKER OF OXIDATIVE METABOLIC PATHWAY GENE EXPRESSION.” In NEURO-ONCOLOGY, 18:173–173, 2016.
Miller K, Berendsen S, Seute T, Yeom K, Gephardt M, Grant G, et al. FRACTAL STRUCTURE IN THE VOLUMETRIC CONTRAST ENHANCEMENT OF MALIGNANT GLIOMAS AS A MARKER OF OXIDATIVE METABOLIC PATHWAY GENE EXPRESSION. In: NEURO-ONCOLOGY. 2016. p. 173–173.
Miller, Kai, et al. “FRACTAL STRUCTURE IN THE VOLUMETRIC CONTRAST ENHANCEMENT OF MALIGNANT GLIOMAS AS A MARKER OF OXIDATIVE METABOLIC PATHWAY GENE EXPRESSION.” NEURO-ONCOLOGY, vol. 18, 2016, pp. 173–173.
Miller K, Berendsen S, Seute T, Yeom K, Gephardt M, Grant G, Robe P. FRACTAL STRUCTURE IN THE VOLUMETRIC CONTRAST ENHANCEMENT OF MALIGNANT GLIOMAS AS A MARKER OF OXIDATIVE METABOLIC PATHWAY GENE EXPRESSION. NEURO-ONCOLOGY. 2016. p. 173–173.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 2016
Volume
18
Start / End Page
173 / 173
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis